Cargando…

Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models

Coronavirus disease 2019 (COVID-19) in humans has a wide range of presentations, ranging from asymptomatic or mild symptoms to severe illness. Suitable animal models mimicking varying degrees of clinical disease manifestations could expedite development of therapeutics and vaccines for COVID-19. Her...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choudhary, Shambhunath, Kanevsky, Isis, Yildiz, Soner, Sellers, Rani S., Swanson, Kena A., Franks, Tania, Rathnasinghe, Raveen, Munoz-Moreno, Raquel, Jangra, Sonia, Gonzalez, Olga, Meade, Philip, Coskran, Timothy, Qian, Jessie, Lanz, Thomas A., Johnson, Jillian G., Tierney, Cassandra A, Smith, Justin D., Tompkins, Kristin, Illenberger, Arthur, Corts, Paula, Ciolino, Tara, Dormitzer, Philip R., Dick, Edward J., Shivanna, Vinay, Hall-Ursone, Shannan, Cole, Journey, Kaushal, Deepak, Fontenot, Jane A., Martinez-Romero, Carles, McMahon, Meagan, Krammer, Florian, Schotsaert, Michael, García-Sastre, Adolfo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819578/ https://www.ncbi.nlm.nih.gov/pubmed/35128980 http://dx.doi.org/10.1177/01926233211072767

Ejemplares similares

The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine
por: Jangra, Sonia, et al.
Publicado: (2022)

Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia
por: Chang, Lauren A., et al.
Publicado: (2023)

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
por: Jangra, Sonia, et al.
Publicado: (2021)

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
por: Jangra, Sonia, et al.
Publicado: (2021)

Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice
por: Jangra, Sonia, et al.
Publicado: (2023)

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model
por: Amanat, Fatima, et al.
Publicado: (2020)

Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
por: Amanat, Fatima, et al.
Publicado: (2021)

A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine
por: Jangra, Sonia, et al.
Publicado: (2021)

The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization
por: Zou, Jing, et al.
Publicado: (2021)

Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes
por: Nogales, Aitor, et al.
Publicado: (2021)

Animal models for studying COVID-19, prevention, and therapy: Pathology and disease phenotypes
por: Choudhary, Shambhunath, et al.
Publicado: (2022)

Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Isoniazid and rifapentine treatment effectively reduces persistent M. tuberculosis infection in macaque lungs
por: Sharan, Riti, et al.
Publicado: (2022)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice
por: Jangra, Sonia, et al.
Publicado: (2023)

Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model
por: Sharan, Riti, et al.
Publicado: (2022)

The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters
por: García-Bernalt Diego, Juan, et al.
Publicado: (2023)

Cell-type deconvolution of bulk RNA-Seq from kidney using opensource bioinformatic tools
por: Riojas, Angelica M., et al.
Publicado: (2023)

Inhibition of indoleamine dioxygenase leads to better control of tuberculosis adjunctive to chemotherapy
por: Singh, Bindu, et al.
Publicado: (2023)

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
por: White, Kris M., et al.
Publicado: (2021)

2781. Statistical Modeling to Predict Maternal RSV Vaccine Efficacy from Neutralizing Titers
por: Cai, Bing, et al.
Publicado: (2019)

Rescue of alveolar wall liquid secretion blocks fatal lung injury due to influenza-staphylococcal coinfection
por: Tang, Stephanie, et al.
Publicado: (2023)

Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine
por: Jangra, Sonia, et al.
Publicado: (2020)

Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera
por: Rathnasinghe, Raveen, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera
por: Muik, Alexander, et al.
Publicado: (2021)

Vaccination against Viruses
por: Greenberg, Harry B., et al.
Publicado: (2016)

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
por: Shi, Pei-Yong, et al.
Publicado: (2021)

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
por: Xie, Xuping, et al.
Publicado: (2021)

Syrian Wives
Publicado: (1888)

Limited extent and consequences of pancreatic SARS-CoV-2 infection
por: van der Heide, Verena, et al.
Publicado: (2022)

Historia de la filosofía del derecho
por: Corts Grau, José
Publicado: (1960)

Matemáticas para aprender a pensar : el papel de las creencias en la resolución de problemas /
por: Vila Corts, Antoni
Publicado: (2004)

How to calculate options prices and their Greeks: exploring the black scholes model from delta to vega
por: Ursone, Pierino
Publicado: (2015)

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses
por: Sun, Weina, et al.
Publicado: (2021)

Structure-based antigen design: a strategy for next generation vaccines
por: Dormitzer, Philip R., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_r1g6apd1v18pfpvv411idpckr4